The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,355.00
Bid: 2,360.00
Ask: 2,361.00
Change: -16.00 (-0.67%)
Spread: 1.00 (0.042%)
Open: 2,371.00
High: 2,386.00
Low: 2,355.00
Prev. Close: 2,371.00
BATS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

28 Feb 2019 07:00

RNS Number : 3435R
British American Tobacco PLC
28 February 2019
 

28 February 2019

 

BRITISH AMERICAN TOBACCO ANNOUNCES FINANCE DIRECTOR'S RETIREMENT

 

British American Tobacco p.l.c. (BAT) announces that, after 30 years with the Company and 11 years as Finance Director, Ben Stevens has informed the Company of his intention to step down as Finance Director on reaching the age of 60 and will retire from the Board on 5 August 2019. 

 

Ben will be succeeded as Finance Director by Tadeu Marroco, currently Director, Group Transformation. Prior to his appointment on 5 August 2019, Tadeu will be appointed as Deputy Finance Director with effect from 1 March 2019, in addition to his current role.

 

Tadeu joined BAT in Brazil 26 years ago. Having been Regional Finance Controller, EEMEA, and Group Finance Controller, he was appointed to the Management Board in September 2014 as Director, Business Development. In December 2016 he was appointed Regional Director, Western Europe, becoming Regional Director, Europe and North Africa in January 2018, before taking up his current role in January 2019.

 

Richard Burrows, Chairman of BAT, said: "Throughout his long and varied career at BAT, Ben contributed an enormous amount to making BAT the Company it is today. In particular, Ben has been an outstanding Finance Director who has been instrumental in ensuring that the Company has, over many years, delivered consistent earnings and dividend growth. I am confident that BAT is now well positioned to take advantage of today's exciting future opportunities with its potentially reduced risk products. On behalf of the Board, I would like to thank Ben for his leadership and his invaluable contribution to the Company over the past 30 years."

 

"I would also like to welcome Tadeu to the Board. His success as a Regional Director and the broad experience he has gained in other roles over his 26-year career with BAT makes him ideally placed to assist our CEO Jack Bowles as we accelerate our transformation agenda."

 

Commenting on his decision to retire, Ben Stevens said: "In my 30 years with BAT, I have lived through many changes and I am proud to have been part of the management team that has turned BAT into the dynamic and truly international multi category tobacco and nicotine company that it is today.

I am particularly pleased that the Board has decided to appoint Tadeu as my successor and am confident that he will play a key role in delivering our ambition to transform our Company and our industry."

 

 

Notes to Editors

 

Ben Stevens - career at BAT

1990: Takes up first role with BAT as Regional Finance Controller for East Africa and South Asia.1992: Becomes Regional Finance Controller for BAT's Europe area.1994: Moves to BAT Switzerland where he takes up a variety of roles in the Marketing function.1995: Becomes Chairman and Managing Director of Pakistan Tobacco Company.1997: Takes up the role of Chairman and Managing Director with BAT Russia.1998: Moves back to the UK to take up the role of Head of Corporate Affairs for BAT .2000: Becomes Head of Merger Integration, overseeing the £7bn integration between BAT and Rothmans.2001: Joins the BAT Management Board as Development Director, responsible for the Smoking Tobacco and Cigars division, Mergers & Acquisitions, IT, Corporate Strategy and e-business ventures. 2004: Becomes Regional Director for BAT's Europe area.March 2008: Takes a seat on the BAT Board before becoming Group Finance Director the following month.

August 2019: Retires as Finance Director.

 

 

About British American Tobacco

British American Tobacco is one of the world's leading, multi-category consumer goods companies, that provides tobacco and nicotine products to millions of consumers around the world.

It employs over 55,000 people, with market leadership in over 55 countries and factories in 42. Its Strategic Portfolio is made up of its global cigarette brands and an increasing range of potentially reduced-risk products, comprising vapour and tobacco heating products, as well as oral tobacco and nicotine products such as modern white oral products and more traditional products such as moist snuff and snus.

 

Enquiries:

 

Press Office Anna Vickerstaff / George Parker+44 (0) 20 7845 2888 (24 hours) | @BATPress 

 

Investor RelationsMike Nightingale / Rachael Brierley / John Harney+44 (0) 20 7845 1180 / 1519 / 1263

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOADMGZZNNDGLZM
Date   Source Headline
4th Dec 20239:24 amRNSDirectorate Change
24th Nov 20232:30 pmRNSDirector/PDMR Shareholding
13th Nov 20233:00 pmRNSDirector/PDMR Shareholding
13th Nov 20232:15 pmRNSDirector/PDMR Shareholding
8th Nov 20239:55 amRNSDirector/PDMR Shareholding
8th Nov 20239:50 amRNSDirector/PDMR Shareholding
8th Nov 20239:45 amRNSDirector/PDMR Shareholding
2nd Nov 20231:15 pmRNSDirector/PDMR Shareholding
2nd Nov 20237:00 amRNSBAT Appoints Chief Financial Officer
1st Nov 202312:10 pmRNSTotal Voting Rights
13th Oct 20237:00 amRNSBAT Appoints Chief People Officer
5th Oct 20231:00 pmRNSDirector/PDMR Shareholding
5th Oct 20237:00 amRNSDirectorate Change
2nd Oct 20231:40 pmRNSTotal Voting Rights
26th Sep 20232:40 pmRNSDirector/PDMR Shareholding
18th Sep 20237:00 amRNSBranch Register: Dividend Finalisation Information
14th Sep 20239:00 amRNSRussia business update - sale completed
12th Sep 20233:05 pmRNSDirector/PDMR Shareholding
7th Sep 20231:15 pmRNSDirector/PDMR Shareholding
7th Sep 20237:00 amRNSRussia business update – agreement signed
1st Sep 202310:30 amRNSTotal Voting Rights
24th Aug 20233:40 pmRNSDirector/PDMR Shareholding
22nd Aug 20234:50 pmRNSDirector/PDMR Shareholding
22nd Aug 20233:50 pmRNSDirector/PDMR Shareholding
22nd Aug 202312:25 pmRNSDirector/PDMR Shareholding
22nd Aug 202312:20 pmRNSDirector/PDMR Shareholding
22nd Aug 202312:15 pmRNSDirector/PDMR Shareholding
22nd Aug 20237:00 amRNSCompany Secretary Change
14th Aug 20234:53 pmRNSTender Offer Pricing
14th Aug 202311:30 amRNSResult of Tender Offer
3rd Aug 20233:30 pmRNSDirector/PDMR Shareholding
3rd Aug 202310:20 amRNSPublication of Supplementary Prospectus
1st Aug 202311:38 amRNSPricing Notes Offering
1st Aug 202310:35 amRNSTotal Voting Rights
31st Jul 20231:26 pmRNSTender Offer
26th Jul 20237:00 amRNSHalf-year Report
6th Jul 20233:00 pmRNSDirector/PDMR Shareholding
4th Jul 20237:00 amRNSBranch Register: Dividend Finalisation Information
3rd Jul 20231:40 pmRNSBlock listing Interim Review
3rd Jul 20231:30 pmRNSTotal Voting Rights
20th Jun 202311:00 amRNSDirector/PDMR Shareholding
19th Jun 20237:00 amRNSManagement Board Changes
8th Jun 202312:45 pmRNSDirector/PDMR Shareholding
6th Jun 202310:00 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNS2023 First Half Pre-Close Trading Update
1st Jun 202311:00 amRNSTotal Voting Rights
31st May 202310:45 amRNSDirector/PDMR Shareholding
24th May 20234:35 pmRNSDirector/PDMR Shareholding
22nd May 20232:00 pmRNSHolding(s) in Company
15th May 20237:00 amRNSBAT announces Tadeu Marroco as Chief Executive

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.